182 related articles for article (PubMed ID: 2868411)
1. Expression of beta-adrenergic receptors in synchronous and asynchronous S49 lymphoma cells. I. Receptor metabolism after irreversible blockade of receptors and in cells traversing the cell division cycle.
Mahan LC; Insel PA
Mol Pharmacol; 1986 Jan; 29(1):7-15. PubMed ID: 2868411
[TBL] [Abstract][Full Text] [Related]
2. Expression of beta-adrenergic receptors in synchronous and asynchronous S49 lymphoma cells. II. Relationship between receptor number and response.
Mahan LC; Insel PA
Mol Pharmacol; 1986 Jan; 29(1):16-22. PubMed ID: 3003560
[TBL] [Abstract][Full Text] [Related]
3. Characterization of a bromoacetylated derivative of pindolol as a high affinity, irreversible beta adrenergic antagonist in cultured cells.
Jasper JR; Motulsky HJ; Insel PA
J Pharmacol Exp Ther; 1988 Mar; 244(3):820-4. PubMed ID: 2908047
[TBL] [Abstract][Full Text] [Related]
4. Turnover of beta 1- and beta 2-adrenergic receptors after down-regulation or irreversible blockade.
Neve KA; Molinoff PB
Mol Pharmacol; 1986 Aug; 30(2):104-11. PubMed ID: 3016496
[TBL] [Abstract][Full Text] [Related]
5. Desensitization and resensitization of beta-adrenergic receptors in a smooth muscle cell line.
Scarpace PJ; Baresi LA; Sanford DA; Abrass IB
Mol Pharmacol; 1985 Dec; 28(6):495-501. PubMed ID: 2867463
[TBL] [Abstract][Full Text] [Related]
6. Agonist-mediated regulation of alpha 1- and beta 2-adrenergic receptor metabolism in a muscle cell line, BC3H-1.
Hughes RJ; Insel PA
Mol Pharmacol; 1986 Jun; 29(6):521-30. PubMed ID: 3012317
[TBL] [Abstract][Full Text] [Related]
7. Time-dependent decreases in binding affinity of agonists for beta-adrenergic receptors of intact S49 lymphoma cells. A mechanism of desensitization.
Insel PA; Mahan LC; Motulsky HJ; Stoolman LM; Koachman AM
J Biol Chem; 1983 Nov; 258(22):13597-605. PubMed ID: 6315705
[TBL] [Abstract][Full Text] [Related]
8. Characterization of beta-adrenergic receptors throughout the replicative life span of IMR-90 cells.
Scarpace PJ
J Cell Physiol; 1987 Jan; 130(1):163-7. PubMed ID: 3027107
[TBL] [Abstract][Full Text] [Related]
9. Characterization of monoclonal antibodies to the beta-adrenergic antagonist alprenolol as models of the receptor binding site.
Sawutz DG; Sylvestre D; Homcy CJ
J Immunol; 1985 Oct; 135(4):2713-8. PubMed ID: 2993414
[TBL] [Abstract][Full Text] [Related]
10. Beta adrenergic receptor repopulation of C6 glioma cells after irreversible blockade and down regulation.
Homburger V; Pantaloni C; Lucas M; Gozlan H; Bockaert J
J Cell Physiol; 1984 Dec; 121(3):589-97. PubMed ID: 6094600
[TBL] [Abstract][Full Text] [Related]
11. Agonist-induced changes in the properties of beta-adrenergic receptors on intact S49 lymphoma cells. Time-dependent changes in the affinity of the receptor for agonists.
Hoyer D; Reynolds EE; Molinoff PB
Mol Pharmacol; 1984 Mar; 25(2):209-18. PubMed ID: 6142414
[TBL] [Abstract][Full Text] [Related]
12. Intact cell binding properties of cells expressing altered beta-adrenergic receptors.
Zhu SJ; Toews ML
Mol Pharmacol; 1994 Feb; 45(2):255-61. PubMed ID: 7906855
[TBL] [Abstract][Full Text] [Related]
13. Receptors for beta-adrenergic agonists in cultured chick ventricular cells. Relationship between agonist binding and physiologic effect.
Marsh JD; Smith TW
Mol Pharmacol; 1985 Jan; 27(1):10-8. PubMed ID: 2981398
[TBL] [Abstract][Full Text] [Related]
14. Beta-adrenoceptor metabolism in wild-type, Gs, and protein kinase A-variant S49 cells.
Jasper JR; Motulsky HJ; Mahan LC; Insel PA
Am J Physiol; 1990 Jul; 259(1 Pt 1):C41-6. PubMed ID: 1973600
[TBL] [Abstract][Full Text] [Related]
15. Quantitative comparison of bromoacetylated derivatives of alprenolol and pindolol on beta-adrenergic receptor binding and mobility in S49 cells.
Box RJ
J Recept Res; 1989; 9(4-5):385-403. PubMed ID: 2574237
[TBL] [Abstract][Full Text] [Related]
16. Differential recovery of beta adrenoreceptor antagonist and agonist high affinity binding sites in the guinea-pig lung after irreversible blockade.
Nelson CA; Muther TF; Pitha J; Baker SP
J Pharmacol Exp Ther; 1986 Jun; 237(3):830-6. PubMed ID: 2872326
[TBL] [Abstract][Full Text] [Related]
17. (-)-[125I]-iodopindolol, a new highly selective radioiodinated beta-adrenergic receptor antagonist: measurement of beta-receptors on intact rat astrocytoma cells.
Barovsky K; Brooker G
J Cyclic Nucleotide Res; 1980; 6(4):297-307. PubMed ID: 6110683
[TBL] [Abstract][Full Text] [Related]
18. Distinctions in beta-adrenergic receptor interactions with the magnesium-guanine nucleotide coupling proteins in turkey erythrocyte and S49 lymphoma membranes.
Vauquelin G; Cech SY; André C; Strosberg AD; Maguire ME
J Cyclic Nucleotide Res; 1982; 8(3):149-62. PubMed ID: 6300206
[TBL] [Abstract][Full Text] [Related]
19. A new approach to determine rates of receptor appearance and disappearance in vivo. Application to agonist-mediated down-regulation of rat renal cortical beta 1- and beta 2-adrenergic receptors.
Snavely MD; Ziegler MG; Insel PA
Mol Pharmacol; 1985 Jan; 27(1):19-26. PubMed ID: 2981399
[TBL] [Abstract][Full Text] [Related]
20. Characterization of cardiac beta-adrenergic receptors in the guinea pig heart: application to study of beta-adrenergic receptors in shock models.
Kaufman TM; Horton JW
J Surg Res; 1993 Nov; 55(5):516-23. PubMed ID: 8231171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
